20 Nov 2024 Compass Lexecon Client the City of Baltimore Awarded Over $260 Million after Jury Determines that Opioid Distributors’ Conduct Contributed to a Public Nuisance Healthcare & Life Sciences
18 Nov 2024 Compass Lexecon Client, The Federal Trade Commission, Granted Preliminary Injunction Pausing the Proposed Merger of Tapestry and Capri Retail
Insights Healthcare & Life Sciences Search Search insight Filters Services… Antitrust & Competition Antitrust & Competition: Mergers Antitrust & Competition: Conduct Mergers & Acquisition Litigation Industries… Healthcare & Life Sciences Healthcare & Life Sciences Clear all Showing 1–3 of 3 results Article • 27 Aug 2024 GCR The Guide to Life Sciences: An Economist’s Perspective on Abuse of Dominance and Killer Acquisitions in the Pharma Industry Article • 05 Dec 2011 The Economic Benefits of Pharmacy Benefit Managers - J. Orszag & K. Green Article • 30 Oct 2002 Lexecon Economist Quoted in New York Times Article, Hospitals Battle For-Profit Groups for Patients
Article • 27 Aug 2024 GCR The Guide to Life Sciences: An Economist’s Perspective on Abuse of Dominance and Killer Acquisitions in the Pharma Industry
Article • 30 Oct 2002 Lexecon Economist Quoted in New York Times Article, Hospitals Battle For-Profit Groups for Patients